During NASH progression, the major function of PTPROt is promoting inflammation via NF-κB-induced transcription and NF-κB-ROS-inflammasome-proinflammatory cytokine axis. This evidence concerns the gene PTPRO and metabolic dysfunction-associated steatohepatitis.